Category: Board

Paris, France and Camberley, UK – 2 November 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the availability of its COVID-19 tests in the UK following implementation of the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (“CTDA”). http://novacyt.com/wp-content/uploads/2021/11/Novacyt-Validation-of-COVID-19-tests-in-the-UK-under-CTDA-FINAL-ENG.pdf

Including launch of two new tests to differentiate between COVID-19 and common winter viruses, and between COVID-19 variants Paris, France and Camberley, UK – 30 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&D update. http://novacyt.com/wp-content/uploads/2021/09/Novacyt-RD-update.pdf

Paris, France and Camberley, UK – 29 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that following the announcement earlier today the Company’s rescheduled Annual General Meeting (AGM) will be held on Monday, 18 October 2021 at 2pm CEST/1pm BST. http://novacyt.com/wp-content/uploads/2021/09/Notice-of-AGM.pdf